Abstract
Extract: The therapeutic response to chemically synthesized 1α-hydroxy-cholecalciferol (1α-OH-D3) was studied in three patients with autosomal recessive vitamin D dependency (ARVDD). The daily maintenance dose for vitamin D2, to prevent signs of vitamin D deficiency in these patients, was 40–54.5 μ/kg, or about 100 times normal (Table 1). Withdrawal of maintenance therapy with vitamin D2 resulted in the ultimate reappearance of the vitamin D depletion syndrome in patients 1 and 2 (Figs. 1 and 2). The third patient presented with the deficiency syndrome despite adequate vitamin D nutrition and was recognized to have ARVDD.
Treatment with 1α-OH-D3 by mouth in all three patients at dose levels of 1–3 μg/24 hr (80–100 ng/kg) corrected hypocalcemia and suppressed parathyroid hormone-dependent renal loss of amino acids (Figs. 1, 2, and 4). Rickets healed in 7–9 weeks on 1α-OH-D3 alone (Fig. 3) The therapeutic response was rapid. It was usually seen first in the rise of serum calcium (Figs. 5 and 6). Withdrawal of 1α-OH-D3 was followed first by a fall of serum phosphorus, then by a fall in serum calcium; the latter occurred within about 2 weeks of withdrawal.
Because the synthesis of 1α-OH-D3 is simpler than for 1α,25-dihydroxycholecalciferol and because the former is an effective therapeutic analog of vitamin D hormone, we believe these studies in ARVDD reveal 1α-OH-D3 to be the agent of choice for treatment of this and analogous diseases.
Speculation: Vitamin D dependency or pseudodeficiency rickets is believed to be an inborn error of vitamin D hormone biosynthesis. The putative abnormal enzyme is 25-hydroxycholecalciferol 1-hydroxylase in the recessively inherited trait. Consequently, this experiment of nature offers a special opportunity to examine the requirement in human subjects, for 1α -hydroxyvitamin D3, metabolites.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reade, T., Scriver, C., Glorieux, F. et al. Response to Crystalline 1α-Hydroxyvitamin D3 in Vitamin D Dependency. Pediatr Res 9, 593–599 (1975). https://doi.org/10.1203/00006450-197507000-00008
Issue Date:
DOI: https://doi.org/10.1203/00006450-197507000-00008
Keywords
This article is cited by
-
Rickets guidance: part II—management
Pediatric Nephrology (2022)
-
Rickets
Nature Reviews Disease Primers (2017)
-
Vitamin D/dietary calcium deficiency rickets and pseudo-vitamin D deficiency rickets
BoneKEy Reports (2014)
-
Renal ultrasound in metabolic bone disease
Pediatric Radiology (1986)